Compare ANVS & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANVS | MOBX |
|---|---|---|
| Founded | 2008 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 111.3M | 52.0M |
| IPO Year | 2020 | N/A |
| Metric | ANVS | MOBX |
|---|---|---|
| Price | $3.79 | $0.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $13.50 | N/A |
| AVG Volume (30 Days) | ★ 4.0M | 954.2K |
| Earning Date | 11-12-2025 | 12-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $10,984,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 180.13 |
| 52 Week Low | $1.11 | $0.40 |
| 52 Week High | $6.37 | $2.47 |
| Indicator | ANVS | MOBX |
|---|---|---|
| Relative Strength Index (RSI) | 51.96 | 52.44 |
| Support Level | $4.12 | $0.52 |
| Resistance Level | $4.64 | $0.59 |
| Average True Range (ATR) | 0.53 | 0.05 |
| MACD | -0.10 | 0.02 |
| Stochastic Oscillator | 18.03 | 87.48 |
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.